Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa ( DART ) : a randomised non-inferiority trial
暂无分享,去创建一个
[1] Ray Y. Chen,et al. Five-Year Outcomes of the China National Free Antiretroviral Treatment Program , 2009, Annals of Internal Medicine.
[2] N. Parkin,et al. The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy , 2009, AIDS.
[3] S. Lawn,et al. Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South Africa , 2009, AIDS.
[4] V. DeGruttola,et al. Five-year outcomes of initial patients treated in Botswana's National Antiretroviral Treatment Program , 2008, AIDS.
[5] Karen Cohen,et al. Antiretroviral therapy and early mortality in South Africa. , 2008, Bulletin of the World Health Organization.
[6] Deenan Pillay,et al. Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model , 2008, The Lancet.
[7] A. Walker,et al. Fixed duration interruptions are inferior to continuous treatment in African adults starting therapy with CD4 cell counts < 200 cells/microl. , 2008, AIDS.
[8] S. Gove,et al. The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings , 2006, The Lancet.
[9] P. Kaleebu,et al. Virological response to a triple nucleoside/nucleotide analogue regimen over 48 weeks in HIV-1-infected adults in Africa , 2006, AIDS.
[10] P. Armitage,et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. , 1976, British Journal of Cancer.
[11] M. H. Gault,et al. Prediction of creatinine clearance from serum creatinine. , 1975, Nephron.
[12] C. Gilks,et al. Cost Effectiveness Analysis of Routine Laboratory or Clinically Driven Strategies for Monitoring Anti-Retroviral Therapy in Uganda and Zimbabwe (DART Trial) , 2009 .
[13] J. Pape,et al. 5-year survival of patients with AIDS receiving antiretroviral therapy in Haiti. , 2009, The New England journal of medicine.
[14] N. French,et al. Survival and Causes of Death, 2 years after introduction of Antiretroviral Therapy in Africa: a historical cohort comparison in Entebbe, Uganda , 2006 .